IBD logo    organized by friedevents.ch
  • Vodcasts
  • Bios
  • About
  • Team
  • Contact

Vodcast All Vodcasts

Recent clinical trial results informing clinical decision making for vedolizumab & anti-IL23 therapy

Recent clinical trial results informing clinical decision making for vedolizumab & anti-IL23 therapy

Added 29. April 2026

Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD

clinical trials Crohn's disease guselkumab IBD mirikizumab ulcerative colitis vedolizumab
©2026 IBD Essentials    Imprint    Data privacy
scroll to top